S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
NYSE:AVNS

Avanos Medical Earnings Date, Estimates, & History

$31.53
-0.42 (-1.31 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$31.48
$31.92
50-Day Range
$31.38
$38.50
52-Week Range
$30.96
$53.61
Volume155,400 shs
Average Volume362,341 shs
Market Capitalization$1.52 billion
P/E Ratio1,051.00
Dividend YieldN/A
Beta0.91

Earnings Summary

Upcoming
Earnings Date
Nov. 2
Estimated

Actual EPS
(Aug. 2)
$0.21
Missed By -$0.02

Consensus EPS
(Aug. 2)
$0.23

Last Year's Q3 EPS
(8/4/2020)
$0.13

Avanos Medical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Avanos Medical Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avanos Medical (NYSE:AVNS) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20211$0.15$0.15$0.15 
Q2 20211$0.26$0.26$0.26 
Q3 20211$0.28$0.28$0.28 
Q4 20211$0.42$0.42$0.42 
FY 20214$1.11$1.11$1.11

AVNS Earnings Information

Avanos Medical last announced its earnings results on August 2nd, 2021. The reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.02. The company earned $186.40 million during the quarter, compared to analysts' expectations of $180.56 million. Its revenue for the quarter was up 13.9% compared to the same quarter last year. Avanos Medical has generated $0.79 earnings per share over the last year ($0.03 diluted earnings per share) and currently has a price-to-earnings ratio of 1,051.0. Earnings for Avanos Medical are expected to grow by 32.76% in the coming year, from $1.16 to $1.54 per share. Avanos Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 2nd, 2021 based off prior year's report dates.

Avanos Medical (NYSE:AVNS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
11/2/2021
(Estimated)
        
8/2/20216/30/2021$0.23$0.21($0.02)($0.36)$180.56 million$186.40 million    
5/6/20213/31/2021$0.18$0.23+$0.05$0.62$175.68 million$181.00 million  
2/17/2021Q4 2020$0.22$0.28+$0.06$1.55$183.77 million$185.00 million  
11/3/20209/30/2020$0.10$0.21+$0.11$0.02$165.87 million$186.00 million  
8/4/20206/30/2020($0.10)$0.13+$0.23$0.32$147.90 million$163.70 million  
5/6/20203/31/2020$0.16$0.16$0.24$175.15 million$180.40 million  
2/25/2020Q4 2019$0.32$0.34+$0.02$0.81$178.58 million$189.80 million  
11/5/2019Q3$0.32$0.30($0.02)$0.84$179.98 million$171.40 million  
8/6/2019Q2 2019$0.25$0.28+$0.03$0.73$172.02 million$172.20 million  
5/7/20193/31/2019$0.17$0.15($0.02)$0.73$163.72 million$164.20 million  
2/26/2019Q4 2018$0.24$0.33+$0.09$0.71$166.88 million$169.90 million  
11/6/20189/30/2018$0.28$0.37+$0.09$0.65$166.57 million$165.10 million  
8/7/2018Q2 2018$0.38$0.48+$0.10$0.23$157.37 million$160.90 million
5/2/2018Q1 2018$0.55$0.76+$0.21$1.09$153.20 million$156.40 million
2/27/2018Q4 2017$0.49$0.73+$0.24$0.77$417.93 million$166.30 million
11/1/2017Q3 2017$0.45$0.60+$0.15$0.85$396.19 million$401.40 million
8/2/2017Q2 2017$0.38$0.51+$0.13$0.66$400.37 million$399.20 million
5/2/2017Q1 2017$0.43$0.48+$0.05$0.69$391.86 million$395.60 million
2/27/2017Q4 2016$0.45$0.50+$0.05$0.79$401.78 million$410.00 million
11/2/2016Q3 2016$0.40$0.48+$0.08$0.77$387.30 million$397.50 million
8/3/2016Q2 2016$0.36$0.45+$0.09$0.76$382.36 million$400.00 million
5/4/2016Q1 2016$0.34$0.53+$0.19$0.76$370.16 million$384.80 million
2/29/2016Q4 2015$0.50$0.57+$0.07$0.83$402.46 million$401.40 million
11/3/2015Q3 2015$0.48$0.52+$0.04$11.14$386.01 million$389.50 million
8/4/2015Q2 2015$0.54$0.52($0.02)$0.87$405.00 million$389.30 million
5/4/2015Q1 2015$0.64$0.51($0.13)$0.56$394.20 million
3/4/2015Q4 2014$0.75$1.59+$0.84$3.23$439.40 million
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles











Avanos Medical (NYSE:AVNS) Earnings Frequently Asked Questions

When is Avanos Medical's earnings date?

Avanos Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 2nd, 2021 based off last year's report dates. Learn more on AVNS's earnings history

Did Avanos Medical beat their earnings estimates last quarter?

In the previous quarter, Avanos Medical (NYSE:AVNS) missed the analysts' consensus estimate of $0.23 by $0.02 with a reported earnings per share (EPS) of $0.21. Learn more on AVNS's earnings details

How can I listen to Avanos Medical's earnings conference call?

The conference call for Avanos Medical's latest earnings report can be listened to online. Listen to Conference Call

How can I read Avanos Medical's conference call transcript?

The conference call transcript for Avanos Medical's latest earnings report can be read online. Read Transcript

How much revenue does Avanos Medical generate each year?

Avanos Medical (NYSE:AVNS) has a recorded annual revenue of $714.80 million.

How much profit does Avanos Medical generate each year?

Avanos Medical (NYSE:AVNS) has a recorded net income of -$27.20 million. AVNS has generated $0.79 earnings per share over the last four quarters.

What is Avanos Medical's price-to-earnings ratio?

Avanos Medical (NYSE:AVNS) has a trailing price-to-earnings ratio of 1,051.00 and a forward price-to-earnings ratio of 27.18.

What is Avanos Medical's EPS forecast for next year?

Avanos Medical's earnings are expected to grow from $1.16 per share to $1.54 per share in the next year, which is a 32.76% increase.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.